Illumina to Provide Genotyping Service for UVA, NIDDK Diabetes Study | GenomeWeb
NEW YORK (GenomeWeb News) — Illumina will handle genotyping services for a joint study for the Type I Diabetes Genetics Consortium that aims to identify genes that influence the risk of developing the disease.
 
Illumina said it will provide its Fast Track Genotyping Services to process more than 6,500 samples for the study, which is being conducted by the Center for Public Health Genomics at the University of Virginia for the National Institute of Diabetes and Digestive and Kidney Diseases.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Startup companies are taking on personalized medicine, CNET reports.

Bruce Booth writes at Life Sci VC that biotech clusters like Boston and San Francisco are getting even more consolidated.

The Verge speaks with Mark and Scott Kelly, who are the subjects of NASA's Twin Study.

In Genome Biology this week: genes linked to Hirschsprung disease, structural variant patterns in autism, and more.